JUNSHI BIO (688180.SH): Shanghai Tan Ying and Shanghai Tan Zheng plan to reduce their holdings of the company's shares by no more than 0.75%.

24/09/2024

GMT Eight

JUNSHI BIO (688180.SH) announced that Shanghai Tanying and Shanghai Tanzheng are optimistic about the company's development in the long term. Due to the fund's term and liquidity arrangements, Shanghai Tanying and Shanghai Tanzheng plan to reduce their holdings of the company's shares in a total amount not exceeding 739,270 shares through centralized bidding and bulk trading, with a cumulative reduction ratio not exceeding 0.75% of the total share capital of the company.

Hubei Hongyuan Pharmaceutical Technology (301246.SZ) supervisors Duan Xiaoliu and Lei Gaoliang have completed their share reduction period and collectively reduced their holdings by 1.1 million shares.

STANCHART (02888) issue 287,500 conditional rights and 9.708 million warrants

Contact: contact@gmteight.com

JUNSHI BIO (688180.SH): Shanghai Tan Ying and Shanghai Tan Zheng plan to reduce their holdings of the company's shares by no more than 0.75%.

RECOMMEND

Jiangsu Canlon Building Materials (300715.SZ) shareholder Jin Jianxin completed reduction of holdings, accumulating a reduction of 2.6568 million shares.

How much more can the U.S. stock market rise this year? Wall Street's highest projection is up to 6100 points.

Shannon Semiconductor Technology (300475.SZ): ChangLe Hui Capital Exclusive 16 proposes to reduce its shareholdings by no more than 1%.